Abstract
The authors wish to make corrections to the authorship and title of [1]. The corrected authorship is as follows: Julia Chisholm and Henry Mandeville contributed equally to the first authorship. Johannes H. M. Merks and Meriel Jenney contributed equally to senior authorship. In the title FAR-RMS has been corrected to FaR-RMS. The authors apologize for any inconvenience caused and state that the scientific conclusions are unaffected. This correction was approved by the Academic Editor. The original publication has also been updated.
| Original language | English |
|---|---|
| Article number | 3427 |
| Journal | Cancers |
| Volume | 16 |
| Issue number | 19 |
| DOIs |
|
| Publication status | Published - Oct 2024 |
Fingerprint
Dive into the research topics of 'Correction to: Frontline and Relapsed Rhabdomyosarcoma (FaR-RMS) Clinical Trial: A Report from the European Paediatric Soft Tissue Sarcoma Study Group (EpSSG) (Cancers, (2024), 16, 5, (998), 10.3390/cancers16050998)'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver